Sukamoto T - Search Results

1

Hara H, Shimazawa M, Hashimoto M, Sukamoto T. Hara H, et al. Among authors: sukamoto t. Nihon Yakurigaku Zasshi. 1998 Oct;112 Suppl 1:138P-142P. doi: 10.1254/fpj.112.supplement_138. Nihon Yakurigaku Zasshi. 1998. PMID: 10190151 Japanese.

2

[The effects of a novel Ca2+ channel blocker, KB-2796, on 5-HT-induced responses].

Fujishima Y, Hara H, Shimazawa M, Yokota K, Sukamoto T. Fujishima Y, et al. Among authors: sukamoto t. Nihon Yakurigaku Zasshi. 1994 Jul;104(1):19-29. doi: 10.1254/fpj.104.19. Nihon Yakurigaku Zasshi. 1994. PMID: 8076888 Japanese.

3

Effect of KB-2796, a new diphenylpiperazine Ca2+ antagonist, on glutamate-induced neurotoxicity in rat hippocampal primary cell cultures.

Hara H, Yokota K, Shimazawa M, Sukamoto T. Hara H, et al. Among authors: sukamoto t. Jpn J Pharmacol. 1993 Apr;61(4):361-5. doi: 10.1254/jjp.61.361. Jpn J Pharmacol. 1993. PMID: 8100595 Free article.

4

Effects of Ca2+ channel blockers on cortical hypoperfusion and expression of c-Fos-like immunoreactivity after cortical spreading depression in rats.

Shimazawa M, Hara H, Watano T, Sukamoto T. Shimazawa M, et al. Among authors: sukamoto t. Br J Pharmacol. 1995 Aug;115(8):1359-68. doi: 10.1111/j.1476-5381.1995.tb16624.x. Br J Pharmacol. 1995. PMID: 8564192 Free PMC article.

5

Inhibitory effect of lomerizine, a diphenylpiperazine Ca2+-channel blocker, on Ba2+ current through voltage-gated Ca2+ channels in PC12 cells.

Watano T, Hara H, Sukamoto T. Watano T, et al. Among authors: sukamoto t. Jpn J Pharmacol. 1997 Oct;75(2):209-13. doi: 10.1254/jjp.75.209. Jpn J Pharmacol. 1997. PMID: 9414039 Free article.

6

Selective effects of lomerizine, a novel diphenylmethylpiperazine Ca2+ channel blocker, on cerebral blood flow in rats and dogs.

Hara H, Shimazawa M, Sasaoka M, Yamada C, Iwakura Y, Sakai T, Maeda Y, Yamaguchi T, Sukamoto T, Hashimoto M. Hara H, et al. Among authors: sukamoto t. Clin Exp Pharmacol Physiol. 1999 Nov;26(11):870-6. doi: 10.1046/j.1440-1681.1999.03154.x. Clin Exp Pharmacol Physiol. 1999. PMID: 10561807

7

Neurochemical investigation on the effects of a new diphenylpiperazine calcium antagonist, KB-2796, on the central dopaminergic system of rats.

Ikegami A, Ozaki A, Hara H, Sukamoto T, Yamashita A, Ito K. Ikegami A, et al. Among authors: sukamoto t. Jpn J Pharmacol. 1992 Apr;58(4):399-405. doi: 10.1254/jjp.58.399. Jpn J Pharmacol. 1992. PMID: 1405037 Free article.

8

Protective effect of KB-2796, a new calcium antagonist, in cerebral hypoxia and ischemia.

Hara H, Ozaki A, Yoshidomi M, Sukamoto T. Hara H, et al. Among authors: sukamoto t. Arch Int Pharmacodyn Ther. 1990 Mar-Apr;304:206-18. Arch Int Pharmacodyn Ther. 1990. PMID: 2241412

9

[Effect of trazodone (KB-831) and its metabolites on brain monoamines in rat].

Ikegami A, Maeda A, Hara H, Yamashita A, Sukamoto T, Ito K. Ikegami A, et al. Among authors: sukamoto t. Nihon Yakurigaku Zasshi. 1989 Mar;93(3):145-54. doi: 10.1254/fpj.93.145. Nihon Yakurigaku Zasshi. 1989. PMID: 2731805 Japanese.

10

Binding properties of KB-5492, a novel anti-ulcer agent, at sigma receptors in porcine gastric fundic mucosa.

Harada Y, Hara H, Sukamoto T. Harada Y, et al. Among authors: sukamoto t. Eur J Pharmacol. 1994 Aug 11;261(1-2):91-6. doi: 10.1016/0014-2999(94)90305-0. Eur J Pharmacol. 1994. PMID: 8001658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters